Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
ResMed Inc | Salute | Shane Ponraj | Equity Analyst | 26/04/2024 | ||
ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh | Salute | Shane Ponraj | Equity Analyst | 26/04/2024 | ||
West Pharmaceutical Services Inc | Salute | Jay Lee | Senior Equity Analyst | 26/04/2024 | ||
Evotec SE | Salute | Rachel Elfman | Equity Analyst | 26/04/2024 | ||
Evotec SE ADR | Salute | Rachel Elfman | Equity Analyst | 26/04/2024 | ||
Icon PLC | Salute | Rachel Elfman | Equity Analyst | 26/04/2024 | ||
Sanofi SA | Salute | Damien Conover | Sector Director | 26/04/2024 | ||
Sanofi SA ADR | Salute | Damien Conover | Sector Director | 26/04/2024 | ||
AstraZeneca PLC | Salute | Damien Conover | Sector Director | 26/04/2024 | ||
AstraZeneca PLC ADR | Salute | Damien Conover | Sector Director | 26/04/2024 | ||
Swedish Orphan Biovitrum AB | Salute | Karen Andersen | Strategist | 25/04/2024 | ||
Bristol-Myers Squibb Co | Salute | Damien Conover | Sector Director | 25/04/2024 | ||
Laboratory Corp of America Holdings | Salute | Debbie Wang | Senior Equity Analyst | 25/04/2024 | ||
Chugai Pharmaceutical Co Ltd | Salute | Jay Lee | Senior Equity Analyst | 25/04/2024 | ||
Align Technology Inc | Salute | Keonhee Kim | Equity Analyst | 25/04/2024 | ||
Eurofins Scientific SE | Salute | Jay Lee | Senior Equity Analyst | 25/04/2024 | ||
Biomarin Pharmaceutical Inc | Salute | Karen Andersen | Strategist | 25/04/2024 | ||
Ipsen SA | Salute | Rachel Elfman | Equity Analyst | 25/04/2024 | ||
CureVac NV Ordinary Shares | Salute | Rachel Elfman | Equity Analyst | 25/04/2024 | ||
Biogen Inc | Salute | Karen Andersen | Strategist | 24/04/2024 |